Nebraska syringe plant ups production to help with vaccine
7 Oct 2021
HOLDREGE, Neb. (AP) — BD has completed an expansion at one of its Nebraska plants that will help the company continue providing hundreds of millions of needles and syringes to the U.S. government to help with the COVID-19 vaccination campaign.
The company said Thursday that the $70 million expansion of production lines at its plant in Holdrege, Nebraska, was completed with the help of a $42 million investment from the U.S. Department of Health and Human Services.
“As the fight against COVID-19 continues, we are steadfast in our commitment to securing the nation’s supply continuity of these critical injection devices,” said Rick Byrd, president of Medication Delivery Solutions for BD.